2.5 of tirzepatide Dosage Chart & Dosing Guide for Weight Loss Have you ever heard of

Discover how GLP-1 agonists, known for treating diabetes and obesity, are now being studied for their potential in tackling heart diseases.

Scott Harris, M.D., will be discussing the promise of #GLP1/#Glucagon approaches in treating #MASH and #MASLD, as well as the importance of developing therapies tailored to the specific needs of patients with #obesity and/or #MASH

Excess weight is a key contributor because excess fatty tissuecan narrow the airway and intensify sleep disruptions

Researchers are currently exploring its effects on glucose regulation, insulin sensitivity, and energy balance in pre-clinical settings.

Choose Empower Pharmacy for Sildenafil Tablets